Literature DB >> 3187984

Median sternotomy as an approach for pulmonary surgery.

Y Watanabe1, T Ichihashi, T Iwa.   

Abstract

A median sternotomy incision was employed in 73 cases of pulmonary surgery instead of posterolateral thoracotomy. An anterior mediastinal approach was used in three groups of patients: group 1 patients (47 cases) underwent simultaneous bilateral surgery for pulmonary disorders on both sides, in group 2 patients (15 cases), this approach was selected to facilitate surgery on the involved mediastinal structures, and group 3 patients (11 cases) had left lung cancer with extensive dissection of lymph nodes done via median sternotomy, as well as routine dissection of nodes by posterolateral thoracotomy. A median sternotomy approach for pulmonary surgery provided an excellent operative field, and most patients experienced less postoperative pain and a quicker recovery. The surgical indications for this approach, the surgical procedure, the results, and the advantages and disadvantages of using a median sternotomy incision are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3187984     DOI: 10.1055/s-2007-1020084

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

1.  Lung volumes following resection of pulmonary metastases in paediatric patients--a retrospective study.

Authors:  K P Paul; H Toomes; I Vogt-Moykopf
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

2.  Anatomic basis of lymphatic spread of lung carcinoma to the mediastinum: anatomo-clinical correlations.

Authors:  M Riquet; D Manac'h; P Dupont; A Dujon; G Hidden; B Debesse
Journal:  Surg Radiol Anat       Date:  1994       Impact factor: 1.246

Review 3.  Mediastinal lymph nodes: ignore? sample? dissect? The role of mediastinal node dissection in the surgical management of primary lung cancer.

Authors:  Jean Deslauriers
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-09

Review 4.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.